| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/10/2004 | WO2004047810A1 Mannose-based fast dissolving tablets |
| 06/10/2004 | WO2004047809A1 Stable pharmaceutical compositions without a stabilizer |
| 06/10/2004 | WO2004047808A1 Pharmaceutical compositions comprising amoxicillin and clavulanic acid |
| 06/10/2004 | WO2004047807A1 Artificial blood on the basis of encapsulted haemoglobin |
| 06/10/2004 | WO2004047806A1 Process for obtaining bacterium-size particles |
| 06/10/2004 | WO2004047805A1 Method of obtaining cochlear structures, vaccine compositions, adjuvants and intermediates thereof |
| 06/10/2004 | WO2004047804A1 Emulsion of perfluororganic compounds exhibiting gas-transport properties, a surface-active agent for said emulsion and method for the production thereof. |
| 06/10/2004 | WO2004047802A2 Liposomal formulations |
| 06/10/2004 | WO2004047801A2 Method of drug loading in liposomes by gradient |
| 06/10/2004 | WO2004047800A2 Method of drug loading in liposomes by gradient |
| 06/10/2004 | WO2004047799A2 Pellets containing non-aqueous fluids and the process for their preparation |
| 06/10/2004 | WO2004047798A2 Formulations of finasteride |
| 06/10/2004 | WO2004047797A2 Crystallization method and apparatus using an impinging plate assembly |
| 06/10/2004 | WO2004047796A2 Pulverulent formulation for inhalation containing tiotropium |
| 06/10/2004 | WO2004047795A2 Cutaneous application of flupirtine |
| 06/10/2004 | WO2004047794A2 An allergen dosage form |
| 06/10/2004 | WO2004047793A1 Pharmaceutical allergen product |
| 06/10/2004 | WO2004047792A2 Liposomal glucocorticoids |
| 06/10/2004 | WO2004047785A1 Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
| 06/10/2004 | WO2004047784A1 Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
| 06/10/2004 | WO2004047752A2 Pharmaceutical formulations of celcoxib |
| 06/10/2004 | WO2004047729A2 Composition for the prevention and treatment of inflammation of the ear |
| 06/10/2004 | WO2004047718A2 Process for manufacturing sustained release microbeads containing venlafaxine hci |
| 06/10/2004 | WO2004047713A2 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 06/10/2004 | WO2004047673A2 Treatment of liver disease with active vitamin d compounds |
| 06/10/2004 | WO2004047564A1 Novel pharmaceutical compositions in particular for preventing cardiovascular pathologies |
| 06/10/2004 | WO2004035093A3 Polymeric materials for site specific delivery to the body |
| 06/10/2004 | WO2004033484A3 Use of stable glutamine derivatives to improve drug absorption |
| 06/10/2004 | WO2004032905A8 Gabapentin tablets and methods for their preparation |
| 06/10/2004 | WO2004030743A3 Drug delivery device having coated microprojections incorporating vasoconstrictors |
| 06/10/2004 | WO2004027372A3 Method for diagnosing rhabdomyosarcoma and pharmaceutical compositions for the treatment and/or prevention of rhabdomyosarcoma |
| 06/10/2004 | WO2004026262A3 Abuse-resistant pharmaceutical compositions |
| 06/10/2004 | WO2004026241A3 Multistage formulation containing a biguanide and thiazolidindione derivatives |
| 06/10/2004 | WO2004023979A3 Mucus formulation for mucosal surfaces and uses thereof |
| 06/10/2004 | WO2004022000A3 Antibiotic microspheres for treatment of infections and osteomyelitis |
| 06/10/2004 | WO2004011368A3 Low temperature anodic bonding method using focused energy for assembly of micromachined systems |
| 06/10/2004 | WO2004009666A3 Dendrimers as molecular translocators |
| 06/10/2004 | WO2004009445A3 Packaging and dispensing of rapid dissolve dosage form |
| 06/10/2004 | WO2004003145A3 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 06/10/2004 | WO2004002447A3 Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton |
| 06/10/2004 | WO2003106592A3 Ether alcohols used as solvents and emulsifiers and dispersions containing said ether alcohols |
| 06/10/2004 | WO2003101952A3 Polyamine-mediated transfection |
| 06/10/2004 | WO2003090692A9 Make-up applicator with led light source |
| 06/10/2004 | WO2003087323A3 Biologic modulations with nanoparticles |
| 06/10/2004 | WO2003070191A8 Tamper-resistant transdermal opioid delivery devices |
| 06/10/2004 | WO2003066842A3 Method for producing recombinant proteins in micro-organisms |
| 06/10/2004 | WO2003035080A3 A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 06/10/2004 | WO2003035049A3 Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections |
| 06/10/2004 | WO2003032946A3 Ph-sensitive liposomes for targeted drug delivery |
| 06/10/2004 | WO2003024433A3 Compositions for treatment of common cold, comprising ipratropium and xylometazoline |
| 06/10/2004 | WO2002038168A3 Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases |
| 06/10/2004 | US20040111144 Barriers for polymeric coatings |
| 06/10/2004 | US20040111080 Methods and implantable devices and systems for long term delivery of a pharmaceutical agent |
| 06/10/2004 | US20040111079 Targeted sanguinous drug solution delivery to a targeted organ |
| 06/10/2004 | US20040110934 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 06/10/2004 | US20040110898 Method for producing capsules containing an active ingredient and having an ultra-thin coating |
| 06/10/2004 | US20040110861 irradiating near-ultraviolet rays to a reaction mixture, containing acrylic monomer component, a photopolymerization initiator, a chain transfer agent and a polymerization solvent; content of acid neutralized state not more than 90 mole % |
| 06/10/2004 | US20040110851 Water-based emulsifier wax gels |
| 06/10/2004 | US20040110845 aqueous inhalation compositions containing albuterol; a buffer, such as citric acid; and a metal chelator, such as EDTA; for treating, preventing, or ameliorating symptoms of bronchoconstrictive disorders such as asthma |
| 06/10/2004 | US20040110843 in a patient suffering from a co-morbid condition comprising placing in the fossa navicularis a semi-solid composition comprising a vasoactive prostaglandin and a penetration enhancer; co-morbid condition is diabetes mellitus, hypertension, etc |
| 06/10/2004 | US20040110842 Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect |
| 06/10/2004 | US20040110839 Compounds and compositions for delivering active agents |
| 06/10/2004 | US20040110828 for treating, lessening, or ameliorating emesis, anorexia, or chronic or AIDS-related wasting syndrome |
| 06/10/2004 | US20040110827 Has the 3S,4S configuration and is >99.90% over the 3R,4R enantiomer; nervous system disorders; chronic neurodegenerative diseases, CNS poisoning, cognition activators; antiinflammatory agents; autoimmune diseases; side effect reduction |
| 06/10/2004 | US20040110813 using less complicated and expensive long-lasting stability of the formulation under different climatic conditions and sufficient solubility of the active substance for sufficient gastrointestinal absorption in the slightly acidic and neutral pH |
| 06/10/2004 | US20040110810 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 06/10/2004 | US20040110781 Pharmaceutical compositions containing indistinguishable drug components |
| 06/10/2004 | US20040110734 Combinations for the treatment of inflammatory disorders |
| 06/10/2004 | US20040110732 Pharmaceutical composition for transdermal or transmucosal administration comprising at least one progestin and/or at least one oestrogen, process for preparing it and uses thereof |
| 06/10/2004 | US20040110709 Genetic modification of the lung as a portal for gene delivery |
| 06/10/2004 | US20040110695 Phospholipid vesicle having exogenous antigen orpolynucleic acid coding for antigen; adapted to be phagocytosed by antigen presenting cells |
| 06/10/2004 | US20040110694 Bioavailability of water insoluble drugs is improved by mixing with polyvinylpyrrolidone carrier; dissolving surfactant and plasticizer/solubilizer in water; spraying solution onto drug/carrier mixture in fluidized bed granulator; extrusion |
| 06/10/2004 | US20040110667 Carrier system for cyclosporin pharmaceutical compositions |
| 06/10/2004 | US20040110661 Rapidly disintegrating tablet comprising an acid-labile active ingredient |
| 06/10/2004 | US20040110659 Reaction of glycol with amine and carbonate to form cabamate for surfactants and detergents |
| 06/10/2004 | US20040109936 Method and apparatus for coating centers |
| 06/10/2004 | US20040109920 Coated carotenoid cyclodextrin complexes |
| 06/10/2004 | US20040109902 Dermatological formulations |
| 06/10/2004 | US20040109900 Method for producing a water-alcohol solution and products based thereon |
| 06/10/2004 | US20040109898 Mixture of glycerin as fluid carrier and capsicum plant extract; sexual disorders |
| 06/10/2004 | US20040109897 Mixture of solid phthalic dialdehyde, anticaking agent and dispersant |
| 06/10/2004 | US20040109896 Herpes viruse infections of the eyes; aqueous suspension of acyclovir, vinyl acetate-vinyl alcohol copolymer and nonionic surfactant |
| 06/10/2004 | US20040109895 Method and composition for delivering zinc to the nasal membrane |
| 06/10/2004 | US20040109894 Free-flowing powder encapsulated in pH sensitive microspheres |
| 06/10/2004 | US20040109893 Drug delivery of bupivacaine |
| 06/10/2004 | US20040109892 Segmented copolyesters as compliant, absorbable coatings and sealants for vascular devices |
| 06/10/2004 | US20040109891 Antidiabetic agents |
| 06/10/2004 | US20040109890 Tablets quickly disintegrated in oral cavity |
| 06/10/2004 | US20040109889 Surface treatment composition for soft substrates |
| 06/10/2004 | US20040109888 Cyclodextrin-based materials, compositions and uses related thereto |
| 06/10/2004 | US20040109886 Reducing drug abuse of narcotics using drug delivery system |
| 06/10/2004 | US20040109869 Transcutaneous immunostimulation |
| 06/10/2004 | US20040109849 Dna vaccines expressing hypervariable vh-cdr3 idiotipic determinants |
| 06/10/2004 | US20040109843 Pharmaceutical composition containing decoy and use of the same |
| 06/10/2004 | US20040109836 comprising comb copolymers based on acryloyldimethyltaurine |
| 06/10/2004 | US20040109828 unique crystalline agglomerates of a first material and a solid binder which are free-flowing, sufficiently bulky and sufficiently stable to be handled, metered and delivered, even in extremely small doses |
| 06/10/2004 | US20040109827 Powdery preparations and proecss for producing the same |
| 06/10/2004 | US20040109826 Stabilized albuterol compositions and method of preparation thereof |
| 06/10/2004 | US20040109825 Elevated temperature storage stable fluid compositions of a delayed-type hypersensitivity (DTH) inducer, e.g., 1-Chloro-2,4 Dinitrobenzene (DNCB) |
| 06/10/2004 | US20040108609 Acid end group poly(D,L-lactide-co-glycolide) copolymers with high glycolide content |